AI Therapeutics
Brad Parry graduated with a Ph.D. from Yale University in the lab of Christine Jacobs-Wagner where he pursued questions in biological physics concerning single living cells. To answer these questions, he developed novel experimental and computational approaches based in machine learning and deep learning to investigate the physical nature of the cytoplasm. After completing his degree, he continued developing and applying deep learning based approaches to investigate questions in cell biology as a research scientist at Yale. He now leads efforts to develop new datasets, algorithms and predict novel disease treatments as the Head of AI at AI Therapeutics.
This person is not in any offices
AI Therapeutics
1 followers
AI Therapeutics is an AI-driven company with a unique ability to match drugs to indications and prosecute through clinical development. AI Therapeutics’ revolutionary approach to drug discovery and development has advanced three drugs into clinical trials.